Your browser doesn't support javascript.
loading
Application of Aidi injection (艾迪注射液) in the bronchial artery infused neo-adjuvant chemotherapy for stage III A non-small cell lung cancer before surgical operation / 中国结合医学杂志
Chin. j. integr. med ; Chin. j. integr. med;(12): 537-541, 2010.
Article em En | WPRIM | ID: wpr-308726
Biblioteca responsável: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To study the effect of Aidi Injection (艾迪注射液,ADI) applied in the bronchial artery, applied in the bronchial artery infused (BAI) neo-adjuvant chemotherapy for stage III A non-small cell lung cancer (NSCLC) before surgical operation.</p><p><b>METHODS</b>The 60 patients with NSCLC stage III A underwent two courses BAI chemotherapy before tumor incision were assigned to two groups, the treatment and the control groups, using a random number table, 30 in each group. ADI (100 mL) was given to the patients in the treatment group by adding into 500 mL of 5% glucose injection for intravenous dripping once daily, starting from 3 days before each course of chemotherapy, and it lasted for 14 successive days, so a total of 28 days of administration was completed. The therapeutic effectiveness and the adverse reaction that occurred were observed, and the levels of T-lymphocyte subsets, natural killer cell activity, and interleukin-2 in peripheral blood were measured before and after the treatment.</p><p><b>RESULTS</b>The effective rate in the treatment group was higher than that in the control group (70.0% vs. 56.7%, P<0.05). Moreover, as compared with the control group, the adverse reaction that occurred in the treatment group was less and mild, especially in terms of bone marrow suppression and liver function damage (P<0.05). Cellular immune function was suppressed in NSCLC patients, but after treatment, it ameliorated significantly in the treatment group, showing significant difference as compared with that in the control group (P<0.05).</p><p><b>CONCLUSION</b>ADI was an ideal auxiliary drug for the patients in stage III A NSCLC received BAI neo-chemotherapy before surgical operation; it could enhance the effectiveness of chemotherapy, ameliorate the adverse reaction and elevate patients' cellular immune function; therefore, it is worthy for spreading in clinical practice.</p>
Assuntos
Texto completo: 1 Base de dados: WPRIM Assunto principal: Patologia / Farmacologia / Cirurgia Geral / Fatores de Tempo / Sangue / Artérias Brônquicas / Infusões Intra-Arteriais / Medicamentos de Ervas Chinesas / Células Matadoras Naturais / Subpopulações de Linfócitos Limite: Adult / Aged / Female / Humans / Male Idioma: En Revista: Chin. j. integr. med Ano de publicação: 2010 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Assunto principal: Patologia / Farmacologia / Cirurgia Geral / Fatores de Tempo / Sangue / Artérias Brônquicas / Infusões Intra-Arteriais / Medicamentos de Ervas Chinesas / Células Matadoras Naturais / Subpopulações de Linfócitos Limite: Adult / Aged / Female / Humans / Male Idioma: En Revista: Chin. j. integr. med Ano de publicação: 2010 Tipo de documento: Article